AliveCor Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
178
- Latest Deal Type
-
Debt
- Latest Deal Amount
-
$25M
- Investors
-
12
AliveCor General Information
Description
Developer of a mobile electrocardiogram device designed to improve stroke prevention through early atrial fibrillation detection. The company's device lets patients monitor their heart health via their smartphones and provides physicians with an additional heart health assessment tool, enabling doctors to instantly analyze and detect atrial fibrillation and normal sinus rhythm in an ECG.
Contact Information
Website
www.alivecor.comCorporate Office
- 189 Bernardo Street
- Suite 100
- Mountain View, CA 94043
- United States
Corporate Office
- 189 Bernardo Street
- Suite 100
- Mountain View, CA 94043
- United States
AliveCor Timeline
AliveCor Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
11. Debt - General | 12-Oct-2022 | $25M | Completed | Generating Revenue | ||
10. Later Stage VC (Series F) | 16-Aug-2022 | Completed | Generating Revenue | |||
9. Later Stage VC (Series E) | 16-Nov-2020 | Completed | Generating Revenue | |||
8. Later Stage VC | 15-Oct-2019 | Completed | Generating Revenue | |||
7. Debt - General | 28-Jan-2019 | Completed | Generating Revenue | |||
6. Later Stage VC (Series D) | 30-Mar-2017 | Completed | Generating Revenue | |||
5. Later Stage VC (Series C) | 14-Apr-2016 | Completed | Generating Revenue | |||
4. Debt - General | 15-Apr-2015 | Completed | Generating Revenue | |||
3. Early Stage VC (Series B) | 11-Jun-2012 | $53.9M | $66.2M | Completed | Generating Revenue | |
2. Early Stage VC (Series A) | 11-Aug-2011 | $8.7M | $12.2M | Completed | Generating Revenue |
AliveCor Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series F | ||||||||
Series E | ||||||||
Series D | ||||||||
Series C2 | ||||||||
Series C1 | ||||||||
Series C | ||||||||
Series B1 | 1,955,187 | $0.000500 | $0.8 | $10.01 | $10.01 | 1x | $10.01 | 2.94% |
Series A1 | 528,730 | $0.000500 | $0.4 | $5 | $5 | 1x | $5 | 0.79% |
AliveCor Comparisons
Industry
Financing
Details
AliveCor Competitors (16)
One of AliveCor’s 16 competitors is Agatsa, a Venture Capital-Backed company based in Noida, India.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Agatsa | Venture Capital-Backed | Noida, India | ||||
CardioDiagnostics | Venture Capital-Backed | Campbell, CA | ||||
BodiMetrics | Venture Capital-Backed | Manhattan Beach, CA | ||||
Huinno | Venture Capital-Backed | Seoul, South Korea | ||||
EHRV | Venture Capital-Backed | Asheville, NC |
AliveCor Patents
AliveCor Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20240152586-A1 | Ecg-based biometric authentication | Pending | 08-Nov-2022 | ||
US-20240041331-A1 | Multi-parameter monitoring device | Pending | 04-Aug-2022 | ||
US-20230326601-A1 | Detection of cardiac conditions from reduced lead set ecg | Pending | 07-Apr-2022 | ||
US-20230263448-A1 | Six lead ecg device with a reduced form factor | Pending | 28-Jan-2022 | ||
US-20230238133-A1 | Ecg search and interpretation based on a dual ecg and text embedding model | Pending | 26-Jan-2022 | G16H50/20 |
AliveCor Signals
AliveCor Investors (12)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
GE HealthCare Technologies | Corporation | Minority | ||
Pegasus Tech Ventures | Corporate Venture Capital | Minority | ||
Sweetwater Private Equity | Secondary Buyer | Minority | ||
Huami Corp | Corporation | Minority | ||
Mayo Clinic | Corporation | Minority |
AliveCor Acquisitions (1)
AliveCor’s most recent deal was a Merger/Acquisition with CardioLabs. The deal was made on 02-Jun-2021.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
CardioLabs | 02-Jun-2021 | Merger/Acquisition | Clinics/Outpatient Services |
AliveCor FAQs
-
When was AliveCor founded?
AliveCor was founded in 2010.
-
Where is AliveCor headquartered?
AliveCor is headquartered in Mountain View, CA.
-
What is the size of AliveCor?
AliveCor has 178 total employees.
-
What industry is AliveCor in?
AliveCor’s primary industry is Monitoring Equipment.
-
Is AliveCor a private or public company?
AliveCor is a Private company.
-
What is AliveCor’s current revenue?
The current revenue for AliveCor is
. -
How much funding has AliveCor raised over time?
AliveCor has raised $318M.
-
Who are AliveCor’s investors?
GE HealthCare Technologies, Pegasus Tech Ventures, Sweetwater Private Equity, Huami Corp, and Mayo Clinic are 5 of 12 investors who have invested in AliveCor.
-
Who are AliveCor’s competitors?
Agatsa, CardioDiagnostics, BodiMetrics, Huinno, and EHRV are some of the 16 competitors of AliveCor.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »